Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 recruiting3 with results

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04004936Not ApplicableCompleted

Reducing Potentially Inappropriate Medication Prescribing for Older Patients in the ED

Role: collaborator

NCT06427356Not ApplicableRecruiting

PREVAIL Interdisciplinary Track: A Pragmatic Randomized Clinical Trial

Role: collaborator

NCT05128006Recruiting

Direct-to-patient Teledermatology and Computer-assisted Diagnosis

Role: collaborator

NCT04350866Completed

Enhancing Access to Insomnia (EASI) Care in VA PCMHI Clinics

Role: collaborator

NCT05563766Phase 2Recruiting

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Role: collaborator

NCT04571619Phase 2Completed

HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis

Role: collaborator

NCT04857008Not ApplicableTerminated

BNT001 Digital Therapeutic Feasibility Pilot Study

Role: collaborator

All 7 trials loaded